// App-Quantinova.ai

SAT0453 : DELAYED DENOSUMAB INJECTIONS AND FRACTURES RISK AMONG SUBJECTS WITH OSTEOPOROSIS: A POPULATION-BASED COHORT STUDY

Researchers

Presenter

  • H. Lyu

Principal Investigators

  • K. Yoshida

  • S. S. Zhao

  • X. Garcia-Albeniz

  • J. Wei

  • C. Zeng

  • S. Tedeschi

  • B. Leder

  • G. Lei

  • P. Tang

  • D. Solomon

Medical Centers

  • National Clinical Research Center for Musculoskeletal Disease, Beijing, China

  • Xiangya Hospital, Central South University, Department of Orthopaedics, Changsha, China

  • University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, United Kingdom

  • RTI Health Solutions, Barcelona, Spain

  • the Second Xiangya Hospital of Central South University, Health Management Center, Changsha, China

  • Massachusetts General Hospital, Endocrine Unit, Department of Medicine, Boston, United States of America

Locations

  • China

  • United States

  • United Kingdom

  • Spain

Companies

  • RTI Health Solutions

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • N/A

Drug/Treatment

  • Denosumab

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Amgen

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved